Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology

European Heart Journal

Volumn 33, Issue 10, 2012, Pages 1268-1278

  Ugander, Martin ^a   Oki, Abiola J ^a   Hsu, Li Yueh ^a   Kellman, Peter ^a   Greiser, Andreas ^b   Aletras, Anthony H ^a   Sibley, Christopher T ^c   Chen, Marcus Y ^a   Patricia Bandettini, W ^a   Arai, Andrew E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b SIEMENS AG   (Germany)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Aging; Fibrosis; Gadolinium; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; EXTRACELLULAR VOLUME IMAGING; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS;

AGED; ANALYSIS OF VARIANCE; CARDIAC VOLUME; CARDIOMYOPATHIES; CONTRAST MEDIA; FIBROSIS; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; OBSERVER VARIATION; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84860917690     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr481     Document Type: Article

References (36)

1. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100: 1992-2002. (Pubitemid 29529292)
2. Mahrholdt H,Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-1474. (Pubitemid 41373486)
3. Arheden H, Saeed M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999; 211:698-708. (Pubitemid 29249466)
4. Thomson LE, Kim RJ, Judd RM. Magnetic resonance imaging for the assessment of myocardial viability. J Magn Reson Imaging 2004;19:771-788. (Pubitemid 38788659)
5. Gazoti Debessa CR, Mesiano Maifrino LB, Rodrigues de Souza R. Age related changes of the collagen network of the human heart. Mech Ageing Dev 2001; 122:1049-1058. (Pubitemid 32520990)
6. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138-144.
7. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversionrecovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 2007;26: 1081-1086. (Pubitemid 47548170)
8. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-383. (Pubitemid 34116807)
9. Messroghli DR, Rudolph A, Abdel-Aty H, Wassmuth R, Kuhne T, Dietz R, Schulz-Menger J. An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging 2010;10:16.
10. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105: 539-542. (Pubitemid 34262671)
11. Hesselstrand R, Scheja A, Wuttge D, Arheden H, Ugander M. Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease. Scand J Rheumatol 2011; 40:133-138.
12. Rodrigues de Souza R. Aging of myocardial collagen. Biogerontology 2002;3: 325-335.
13. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991;68: 1560-1568.
14. Eghbali M, Weber KT. Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem 1990;96:1-14. (Pubitemid 20224147)
15. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 1988;52: 405-414. (Pubitemid 18057397)
16. Robert V, Besse S, Sabri A, Silvestre JS, Assayag P, Nguyen VT, Swynghedauw B, Delcayre C. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest 1997;76:729-738. (Pubitemid 27225102)
17. Janicki JS. Myocardial collagen remodeling and left ventricular diastolic function. Braz J Med Biol Res 1992;25:975-982.
18. Miller TR, Grossman SJ, Schectman KB, Biello DR, Ludbrook PA, Ehsani AA. Left ventricular diastolic filling and its association with age. Am J Cardiol 1986;58: 531-535. (Pubitemid 16052686)
19. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation 1993;87:755-763. (Pubitemid 23070806)
20. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-163. (Pubitemid 24026485)
21. Volders PG, Willems IE, Cleutjens JP, Arends JW, Havenith MG, Daemen MJ. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 1993;25:1317-1323. (Pubitemid 24003838)
22. Marijianowski MM, Teeling P, Becker AE. Remodeling after myocardial infarction in humans is not associated with interstitial fibrosis of noninfarcted myocardium. J Am Coll Cardiol 1997;30:76-82. (Pubitemid 27357128)
23. Montera MW, Drumond C, Takiya C, Mesquita CT, Dohmann HF, Mady C. Correlation of myocardial interstitial collagen in the right ventricular septum with ventricular function of patients with ischemic cardiomyopathy. Arq Bras Cardiol 2009;92:54-62.
24. Sibley CT, Noureldin RA, Gai N, Souto Nacif M, Mudd JO, Halushka MK, Bluemke DA. Abstract 19921: Cardiac MRI T1 mapping noninvasively predicts interstitial myocardial fibrosis in the absence of late gadolinium enhancement. Circulation 2010;122:A19921.
25. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52: 1574-1580.
26. Michel JB, Lattion AL, Salzmann JL, Cerol ML, Philippe M, Camilleri JP, Corvol P. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-650.
27. Sun Y, Zhang JQ, Zhang J, Ramires FJ. Angiotensin II, transforming growth factorbeta1 and repair in the infarcted heart. J Mol Cell Cardiol 1998;30:1559-1569. (Pubitemid 28418646)
28. Collins P, Billings CG, Barer GR, Daly JJ, Jolly A. Quantitation of isoprenaline-induced changes in the ventricular myocardium. Cardiovasc Res 1975;9:797-806.
29. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67: 1355-1364.
30. Hamdani N, Paulus WJ, van Heerebeek L, Borbely A, Boontje NM, Zuidwijk MJ, Bronzwaer JG, Simonides WS, Niessen HW, Stienen GJ, van der Velden J. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction. Eur Heart J 2009;30:1863-1872.
31. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102: 1388-1393.
32. Klein C, Schmal TR, Nekolla SG, Schnackenburg B, Fleck E, Nagel E. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2007;9:653-658. (Pubitemid 46956899)
33. Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, Schwaiger M. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 2004;20: 588-593.
34. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 2010;3:727-734.
35. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295: H1234-H1242.
36. Schelbert EB, Testa SM, Meier CG, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, Shroff SG,Wong TC. Myocardial extravascular extracellular volumefraction measurement by gadoliniumcardiovascular magnetic resonance in humans: slow infusion vs. bolus. J Cardiovasc Magn Reson 2011;13:16.